Cannabis Wire looks back on some of the most significant moments in 2023, and ahead to a potentially historic 2024.
Monday’s hearing follows the adult use bill’s first reading in parliament in October.
The European Monitoring Centre for Drugs and Drug Addiction hosted officials from Malta, Germany, and the Netherlands to share lessons learned.
An adult use bill advanced farther than ever before. But opposition to reforms, and to the president, led to a seven-vote gap.
The phased plan: home cultivation and non-profit clubs are in, while edibles, lounges, and non-residents are out. Eventually, maybe, regulated shops will be allowed.
The International Narcotics Control Board’s latest report, launched Thursday, for the first time devotes its first chapter to cannabis legalization.
From the Hill to the Big Apple to Germany, cannabis conversations reached new heights. Cannabis Wire’s top stories of 2022 cover what’s happened and what’s next.
ASTM International hosted global heavyweights in cannabis industry, research, and regulation for a two-day conference focused on standards.
With a new Congress and a new president, an adult use bill is advancing that could flip the switch by June if not sooner.
Federal Health Minister Karl Lauterbach presented a broad plan to the cabinet on Wednesday, which it supported. Next up: European Commission review.
The country has allowed legal adult use sales since 2018. A mandated review, which kicked off Thursday, will assess outcomes, from youth use to social and environmental impacts.
Bermuda lawmakers advanced an adult use bill this year, but the British overseas territory could not proceed without the approval of the United Kingdom.
The industry will be seen as a player in the economy—and likely legalized—after President-elect Gustavo Petro takes office on August 7.
The country is on track to legalize and regulate cannabis consumption and sales for adults. A public consultation throughout June was the first big step.
Much like in the US, regulators in Europe are grappling with the safety of CBD, as it is already widely used among consumers.
The United Nations annual drug report aims to make sense of an increasingly expansive and complex global cannabis landscape, despite data gaps.